Neoadjuvant Chemoradiotherapy: Clinical Trials

12 trials for Neoadjuvant Chemoradiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 4 completed, 2 recruiting, 1 active not recruiting. 4 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 2, Completed 1, Recruiting 1
Phase 21Unknown 1

Follow Neoadjuvant Chemoradiotherapy: new trials by email Literature Review of Neoadjuvant Chemoradiotherapy trials Research Report on Neoadjuvant Chemoradiotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hyperpolarized 13C-MRI and Radiomics in Rectal Cancer
Hyperpolarized 13C-MRI (HP 13C-MRI) - Neoadjuvant Chemoradiotherapy
RecruitingChang Gung Memorial Hospital302026-06-012026-07-28
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
No interventions - Rectal Cancers, Pathological Complete Response
Active not recruitingPeking University People's Hospital3202026-02-042026-04-03
Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients
Oral Immunonutrition - Pancreatic Cancer, Neoadjuvant Chemoradiotherapy
Not applicableUnknownSun Yat-sen University982024-08-262024-12-17
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
MRD detection - Rectal Adenocarcinoma, Circulating Tumor DNA
UnknownWeiWei Xiao502023-06-212023-08-01
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
PD-1inhibitor - PD-1, Neoadjuvant Chemoradiotherapy
Phase 2UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology322021-03-302024-02-09
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy
RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT - Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1792021-03-172026-07-10
Study on the Applicability of CCR Criteria in Rectal Cancer
PMMR/MSS Adenocarcinoma of the Colon or Rectum, Neoadjuvant Chemoradiotherapy
CompletedPeking University Cancer Hospital & Institute1772019-01-012025-01-27
Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma
Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation, Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation - Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy
Not applicableCompletedZhejiang Cancer Hospital1472018-02-222024-11-18
Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer
Active surveillance - Esophageal Cancer, Active Surveillance
Not applicableUnknownErasmus Medical Center7762017-11-012024-09-19
The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments
Gastric Cancer, Neoadjuvant Chemotherapy
UnknownPeking University6002015-09-012018-04-11
Observational Study on the Patients With Rectal Cancer
Rectal Cancer, Adjuvant Chemoradiotherapy
CompletedChinese Academy of Medical Sciences39952011-01-012016-01-18
Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery
Rectal Resection - Neoadjuvant Chemoradiotherapy, Rectal Tumor
CompletedCampus Bio-Medico University1672005-01-012019-07-09

Narrower conditions

Rectal Neoplasms (5)  ·  Esophageal Neoplasms (2)  ·  Neoplasm, Residual (1)  ·  Pancreatic Neoplasms (1)  ·  Pathologic Complete Response (1)  ·  Stomach Neoplasms (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Digestive System Diseases (9)  ·  Digestive System Neoplasms (9)  ·  Neoplasms (9)  ·  Neoplasms by Site (9)  ·  Gastrointestinal Diseases (8)  ·  Gastrointestinal Neoplasms (8)  ·  Colorectal Neoplasms (5)  ·  Intestinal Diseases (5)  ·  Intestinal Neoplasms (5)  ·  Rectal Diseases (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Esophageal Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Disease Attributes (1)

Interventions

Immunonutrition Diet (1)  ·  Neoadjuvant Therapy (1)  ·  Proctectomy (1)  ·  Watchful Waiting (1)

Sponsors

Campus Bio-Medico University (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chinese Academy of Medical Sciences (1)  ·  Erasmus Medical Center (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Peking University (1)  ·  Peking University Cancer Hospital & Institute (1)  ·  Peking University People's Hospital (1)  ·  Sun Yat-sen University (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  WeiWei Xiao (1)  ·  Zhejiang Cancer Hospital (1)

Countries

China (8)  ·  Italy (1)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Giuditta Chiloiro, MD PhD (1)  ·  Hong-Peng Jiang, docter (1)  ·  Jiafu Ji, M.D., Ph.D. (1)  ·  Weimin Mao, M.D. (1)  ·  Weiwei Xiao (1)  ·  Ying-Chieh Lai, MD (1)

Results publications

PMID 29968240, PMID 32306273, PMID 35033008, PMID 42551632